Antiestrogens are pro‐apoptotic in normal human breast epithelial cells
暂无分享,去创建一个
William Rostène | P. Forgez | W. Rostène | J. Perrot | A. Gompel | Patricia Forgez | Anne Gompel | Marc Chaouat | M. Chaouat | Sonia Somaï | Denis Jacob | Jean‐Yves Perrot | D. Jacob | S. Somaï
[1] A. Howell,et al. Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer. , 1996, British Journal of Cancer.
[2] A. Wakeling,et al. A potent specific pure antiestrogen with clinical potential. , 1991, Cancer research.
[3] H. Horvitz,et al. Mechanisms and functions of cell death. , 1991, Annual review of cell biology.
[4] P. Spritzer,et al. Tamoxifen and hydroxytamoxifen isomers versus estradiol effects on normal human breast cells in culture. , 1988, Cancer research.
[5] B. O’Malley,et al. p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[6] S. Korsmeyer,et al. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death , 1995, Cell.
[7] A. Gompel,et al. Bcl-2 expression in normal endometrium during the menstrual cycle. , 1994, The American journal of pathology.
[8] G. Leclercq,et al. Implication of proteasome in estrogen receptor degradation , 1999, FEBS letters.
[9] P. Spritzer,et al. Progestin effect on cell proliferation and 17 beta-hydroxysteroid dehydrogenase activity in normal human breast cells in culture. , 1986, The Journal of clinical endocrinology and metabolism.
[10] A. Gompel,et al. bcl‐2 expression in normal breast tissue during the menstrual cycle , 1994, International journal of cancer.
[11] William Rostène,et al. Hormonal regulation of apoptosis in breast cells and tissues , 2000, Steroids.
[12] M. Parker,et al. The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. , 1993, Journal of cell science.
[13] P. Bontempo,et al. Estradiol induces functional inactivation of p53 by intracellular redistribution. , 2000, Cancer research.
[14] S. Korsmeyer,et al. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.
[15] G. Teutsch,et al. Exploration of the Therapeutic Potential of the Antiestrogen RU 58668 in Breast Cancer Treatment , 1995, Annals of the New York Academy of Sciences.
[16] C K Redmond,et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.
[17] John Calvin Reed,et al. Identification of a p53-dependent negative response element in the bcl-2 gene. , 1994, Cancer research.
[18] W. Rutter,et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.
[19] E. Gelmann,et al. Effects of steroid hormones and peptide growth factors on protooncogene c-fos expression in human breast cancer cells. , 1988, Cancer research.
[20] H. Michna,et al. The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL‐2 than tamoxifen in MCF‐7 cells , 1999, Breast Cancer Research and Treatment.
[21] A. Gompel,et al. Antagonism between estradiol and progestin on Bcl‐2 expression in breast‐cancer cells , 1996, International journal of cancer.
[22] S. Mandlekar,et al. Pharmacodynamics of tamoxifen and its 4-hydroxy and N-desmethyl metabolites: activation of caspases and induction of apoptosis in rat mammary tumors and in human breast cancer cell lines. , 2000, Cancer research.
[23] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[24] P. Forgez,et al. Quantitative RT-PCR: limits and accuracy. , 1996, BioTechniques.
[25] Emad S. Alnemri,et al. Ordering the Cytochrome c–initiated Caspase Cascade: Hierarchical Activation of Caspases-2, -3, -6, -7, -8, and -10 in a Caspase-9–dependent Manner , 1999, The Journal of cell biology.
[26] W. Rostène,et al. Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells , 1999, The Journal of Steroid Biochemistry and Molecular Biology.
[27] S. Jhanwar,et al. Hormonal Regulation of the p53 Tumor Suppressor Protein in T47D Human Breast Carcinoma Cell Line (*) , 1995, The Journal of Biological Chemistry.
[28] C. Winterford,et al. Apoptosis. Its significance in cancer and cancer Therapy , 1994, Cancer.
[29] M L Agarwal,et al. The p53 Network* , 1998, The Journal of Biological Chemistry.
[30] W. Rostène,et al. In vitro studies of tibolone in breast cells. , 2002, Fertility and sterility.
[31] H. Huynh,et al. Induction of apoptosis in mammary gland by a pure anti-estrogen ICI 182780 , 2001, Breast Cancer Research and Treatment.
[32] G. Palumbo,et al. 17β-Estradiol Inhibits Apoptosis in MCF-7 Cells, Inducing bcl-2 Expression via Two Estrogen-Responsive Elements Present in the Coding Sequence , 2000, Molecular and Cellular Biology.